CDC20 and transitional cell carcinoma: Compared to Urosta cells, CDC20 showed high expression (138.35 fold) in J82 cell line, a representative of epithelial transitional cell carcinoma line, and lower expression (3.98 and 8.47 fold) in HT1197 carcinoma cells and 253JB-V cells, which are metastatic variant at p-value 0.000.